(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are COFINA,SGPS, BE SEMICONDUCTOR, and NEKKAR.

Financial Asset	Price	Change	Updated (EST)
COFINA,SGPS (CFN.LS)	1.07	127.96%	2024-07-03 12:23:09
BE SEMICONDUCTOR (BESI.AS)	170.15	8.76%	2024-07-03 12:00:55
NEKKAR (NKR.OL)	11.30	7.11%	2024-07-03 12:41:27
CAIRN HOMES PLC (C5H.IR)	1.69	7.09%	2024-07-03 12:22:24
ALTAREA (ALTA.PA)	89.00	6.59%	2024-07-03 12:45:41
BENEVOLENTAI (BAI.AS)	0.50	6.38%	2024-07-03 12:00:58
ESTORIL SOL N (ESON.LS)	6.05	6.14%	2024-07-03 12:23:21
NEXT BIOMETRICS GP (NEXT.OL)	8.30	5.06%	2024-07-03 12:41:31
ELLIPTIC LABORATOR (ELABS.OL)	10.96	4.78%	2024-07-03 12:26:01
APERAM (APAM.AS)	25.94	4.26%	2024-07-03 12:00:30

The three biggest losers today are MKB Nedsense, CELYAD ONCOLOGY, and BPOST.

Financial Asset	Price	Change	Updated (EST)
MKB Nedsense (NEDSE.AS)	0.07	-10%	2024-07-03 12:03:07
CELYAD ONCOLOGY (CYAD.BR)	0.26	-9.2%	2024-07-03 12:06:05
BPOST (BPOST.BR)	2.87	-8.45%	2024-07-03 12:05:55
INTEROIL EXPL PROD (IOX.OL)	6.48	-7.46%	2024-07-03 12:40:43
GENTIAN DIAGNOSTIC (GENT.OL)	54.50	-5.22%	2024-07-03 12:40:10
NYKODE THERAPEUTIC (NYKD.OL)	13.88	-5%	2024-07-03 12:41:51
SKUE SPAREBANK (SKUE.OL)	230.10	-4.12%	2024-07-03 12:43:19
IDEX BIOMETRICS (IDEX.OL)	1.45	-3.84%	2024-07-03 12:40:41
OCEANTEAM (OTS.OL)	1.01	-3.83%	2024-07-03 12:41:53
SELVAAG BOLIG (SBO.OL)	37.05	-3.64%	2024-07-03 12:43:11

Winners today

1. COFINA,SGPS (CFN.LS)

127.96% Price Change

Cofina, SGPS, S.A., through its subsidiaries, engages in the publication of newspapers and magazines in Portugal. The company offers newspapers, including Correio da Manha, a daily newspaper; Record, a daily sport newspaper; Negocios, an economic newspaper; and Destak, a free newspaper. It also provides Sábado, an entertainment weekly magazine; TV Guia, weekly television magazine; Máxima, an online publication that develops topics related to culture, fashion, beauty, health and well-being, and travel and lifestyle; Flash, an online publication which addresses the social current affairs of national and international public figures; and Correio da Manhã TV (cmTV), a cable platform. In addition, the company engages in the investment management activities. The company was incorporated in 1990 and is headquartered in Porto, Portugal.

PSI ended the session with COFINA,SGPS rising 127.96% to €1.07 on Wednesday while PSI jumped 1.14% to €6,664.88.

Earnings Per Share

As for profitability, COFINA,SGPS has a trailing twelve months EPS of €-0.16.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on May 17, 2023, the estimated forward annual dividend rate is 0.03 and the estimated forward annual dividend yield is 6.48%.

Moving Average

COFINA,SGPS’s value is way above its 50-day moving average of €0.44 and way above its 200-day moving average of €0.43.

Volume

Today’s last reported volume for COFINA,SGPS is 936490 which is 1009.38% above its average volume of 84416.

Yearly Top and Bottom Value

COFINA,SGPS’s stock is valued at €1.07 at 22:40 EST, way higher than its 52-week high of €0.50.

More news about COFINA,SGPS.

2. BE SEMICONDUCTOR (BESI.AS)

8.76% Price Change

BE Semiconductor Industries N.V. engages in the development, manufacture, marketing, sale, and service of semiconductor assembly equipment for the semiconductor and electronics industries in China, the United States, Malaysia, Ireland, Korea, Taiwan, Thailand, Other Asia Pacific and Europe, and internationally. It operates through three segments: Die Attach, Packaging, and Plating. The company's principal products include die attach equipment, such as single chip, multi-chip, multi module, flip chip, thermal compression bonding, fan out wafer level packaging, hybrid and embedded bridge die bonding, and die sorting systems; and packaging equipment, including conventional, ultra-thin, and wafer level molding, as well as trim and form, and singulation systems. It also provides plating equipment, such as tin, copper, and precious metal and solar plating systems, as well as related process chemicals; and tooling, conversion kits, spare parts, and other services. The company's principal brand names include Datacon, Esec, Fico, and Meco. It offers its products primarily to multinational chip manufacturers, assembly subcontractors, and electronics and industrial companies. BE Semiconductor Industries N.V. was incorporated in 1995 and is headquartered in Duiven, the Netherlands.

AEX-Index ended the session with BE SEMICONDUCTOR rising 8.76% to €170.15 on Wednesday while AEX-Index rose 0.7% to €931.09.

Earnings Per Share

As for profitability, BE SEMICONDUCTOR has a trailing twelve months EPS of €2.24.

PE Ratio

BE SEMICONDUCTOR has a trailing twelve months price to earnings ratio of 75.96. Meaning, the purchaser of the share is investing €75.96 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.81%.

Sales Growth

BE SEMICONDUCTOR’s sales growth is negative 2.6% for the ongoing quarter and 51.3% for the next.

Moving Average

BE SEMICONDUCTOR’s worth is way above its 50-day moving average of €140.47 and way above its 200-day moving average of €132.60.

More news about BE SEMICONDUCTOR.

3. NEKKAR (NKR.OL)

7.11% Price Change

Nekkar ASA provides technologies, software, and automation solutions to offshore energy, renewables, and aquaculture industries. It operates through Syncrolift, Intellilift, and Techano Oceanlift segments. The company offers shipyard solutions, including shiplifting systems for launching and retrievals of vessels, and transfer systems for moving vessels around the yard; FastDocking products for efficient operations during docking and maintenance of vessels; and service and upgrades on shiplift and transfer systems, maintenance, spare replacements, and upgrades of small and larger components. In addition, the company offers load handling and lifting equipment, such as cranes, gangways, and fish transfer systems for the aquaculture and offshore energy industry; FiiZK closed cage solutions to avoid sea lice and enables waste collection from the harvest process; and SkyWalker, a wind turbine installation tool. Further, it develops industrial software solutions for digitalizing workflows through automation and remotely-controlled systems for drilling and offshore load handling. The company operates in Europe, Asia, Australia, New Zealand, North America, the United Arab Emirates, Africa, the United States, South America, India, Norway, and internationally. The company was formerly known as TTS Group ASA and changed its name to Nekkar ASA in July 2019. Nekkar ASA founded in 1966 and is headquartered in Kristiansand, Norway.

Oslo Børs Benchmark Index_GI ended the session with NEKKAR jumping 7.11% to €11.30 on Wednesday, after two successive sessions in a row of gains. Oslo Børs Benchmark Index_GI rose 0.04% to €1,428.23, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, NEKKAR has a trailing twelve months EPS of kr0.76.

PE Ratio

NEKKAR has a trailing twelve months price to earnings ratio of 14.87. Meaning, the purchaser of the share is investing kr14.87 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.49%.

Volume

Today’s last reported volume for NEKKAR is 145786 which is 47.13% above its average volume of 99080.

More news about NEKKAR.

4. CAIRN HOMES PLC (C5H.IR)

7.09% Price Change

Cairn Homes plc, a holding company, operates as a home and community builder in Ireland. The company engages in the development and sale of residential properties, as well as rental of properties. It also provides financial services. Cairn Homes plc was incorporated in 2014 and is based in Dublin, Ireland.

ISEQ All Share ended the session with CAIRN HOMES PLC rising 7.09% to €1.69 on Wednesday while ISEQ All Share jumped 1.22% to €9,425.80.

Earnings Per Share

As for profitability, CAIRN HOMES PLC has a trailing twelve months EPS of €0.13.

PE Ratio

CAIRN HOMES PLC has a trailing twelve months price to earnings ratio of 13.02. Meaning, the purchaser of the share is investing €13.02 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.32%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CAIRN HOMES PLC’s stock is considered to be overbought (>=80).

Moving Average

CAIRN HOMES PLC’s worth is above its 50-day moving average of €1.66 and way above its 200-day moving average of €1.43.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Apr 25, 2024, the estimated forward annual dividend rate is 0.06 and the estimated forward annual dividend yield is 4.03%.

More news about CAIRN HOMES PLC.

5. ALTAREA (ALTA.PA)

6.59% Price Change

Altarea is the French leader in low-carbon urban transformation, with the most comprehensive real estate offering to serve the city and its users. In each of its activities, the Group has all the expertise and recognised brands needed to design, develop, market and manage tailor-made real estate products. Altarea is listed in compartment A of Euronext Paris.

CAC 40 ended the session with ALTAREA jumping 6.59% to €89.00 on Wednesday while CAC 40 jumped 1.24% to €7,632.08.

Earnings Per Share

As for profitability, ALTAREA has a trailing twelve months EPS of €-22.57.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.01%.

Yearly Top and Bottom Value

ALTAREA’s stock is valued at €89.00 at 22:40 EST, way under its 52-week high of €132.00 and way higher than its 52-week low of €67.00.

Volatility

ALTAREA’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.06%, a negative 2.21%, and a positive 2.25%.

ALTAREA’s highest amplitude of average volatility was 1.39% (last week), 3.08% (last month), and 2.25% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth declined by 14%, now sitting on 2.83B for the twelve trailing months.

Moving Average

ALTAREA’s value is way higher than its 50-day moving average of €71.87 and under its 200-day moving average of €94.22.

More news about ALTAREA.

6. BENEVOLENTAI (BAI.AS)

6.38% Price Change

BenevolentAI S.A. operates as a clinical-stage artificial intelligence (AI) enabled drug discovery and development company. Its Benevolent platform integrates AI and science to uncover and develop drugs for complex diseases. The company's development pipeline includes BEN-8744, an oral phosphodiesterase 10 (PDE10) inhibitor under phase 1 study for the treatment of Ulcerative Colitis; BEN-28010, an oral brain penetrant CHK1 inhibitor under preclinical study for the treatment of Glioblastoma Multiforme; BEN-34712, a preclinical candidate for the potential treatment of ALS; and various candidates for the treatment of fibrosis and Parkinson's disease. It has collaboration agreements with AstraZeneca and Merck to enhance understanding of complex disease biology and identify new targets. The company was founded in 2013 and is headquartered in London, United Kingdom.

AEX-Index ended the session with BENEVOLENTAI jumping 6.38% to €0.50 on Wednesday while AEX-Index jumped 0.7% to €931.09.

Earnings Per Share

As for profitability, BENEVOLENTAI has a trailing twelve months EPS of €-0.63.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -51.01%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BENEVOLENTAI’s stock is considered to be overbought (>=80).

Revenue Growth

Year-on-year quarterly revenue growth declined by 64.4%, now sitting on 7.33M for the twelve trailing months.

Yearly Top and Bottom Value

BENEVOLENTAI’s stock is valued at €0.50 at 22:40 EST, way under its 52-week high of €2.66 and higher than its 52-week low of €0.46.

More news about BENEVOLENTAI.

7. ESTORIL SOL N (ESON.LS)

6.14% Price Change

Estoril Sol, SGPS, S.A., together with its subsidiaries, engages in the gaming activities and real estate businesses in Portugal and internationally. It owns gaming casinos, including casino do Estoril, Casino Lisboa, and Casino da Póvoa. It is also involved in the online casino games and gambling business, as well as online sports betting activities. In addition, it owns a plot of land in Monte Estoril. Further, the company engages in tourism business. The company was incorporated in 1958 and is headquartered in Estoril, Portugal. Estoril Sol, SGPS, S.A. is a subsidiary of Finansol – Sociedade de Controlo, SGPS, S.A.

PSI ended the session with ESTORIL SOL N jumping 6.14% to €6.05 on Wednesday while PSI rose 1.14% to €6,664.88.

Earnings Per Share

As for profitability, ESTORIL SOL N has a trailing twelve months EPS of €0.47.

PE Ratio

ESTORIL SOL N has a trailing twelve months price to earnings ratio of 12.87. Meaning, the purchaser of the share is investing €12.87 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.72%.

Yearly Top and Bottom Value

ESTORIL SOL N’s stock is valued at €6.05 at 22:40 EST, under its 52-week low of €6.70.

Volatility

ESTORIL SOL N’s last week, last month’s, and last quarter’s current intraday variation average was a negative 8.77%, a negative 1.73%, and a positive 7.43%.

ESTORIL SOL N’s highest amplitude of average volatility was 8.77% (last week), 9.74% (last month), and 7.43% (last quarter).

More news about ESTORIL SOL N.

8. NEXT BIOMETRICS GP (NEXT.OL)

5.06% Price Change

NEXT Biometrics Group ASA, together with its subsidiaries, provides fingerprint sensor technology in Asia, Europe, Africa, and North America. The company offers fingerprint sensor modules and readers, flexible biometric subassemblies, and face recognition software, as well as software and hardware development kits. It also sells its products to office and notebooks; payment and fintech; access control; and public security sectors. The company sells its sensors to distributors and original equipment manufacturer of electronic components. NEXT Biometrics Group ASA was founded in 2000 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with NEXT BIOMETRICS GP rising 5.06% to €8.30 on Wednesday while Oslo Børs Benchmark Index_GI jumped 0.04% to €1,428.23.

Earnings Per Share

As for profitability, NEXT BIOMETRICS GP has a trailing twelve months EPS of kr-0.68.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -78.69%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NEXT BIOMETRICS GP’s stock is considered to be overbought (>=80).

Volume

Today’s last reported volume for NEXT BIOMETRICS GP is 920899 which is 422.33% above its average volume of 176305.

More news about NEXT BIOMETRICS GP.

9. ELLIPTIC LABORATOR (ELABS.OL)

4.78% Price Change

Elliptic Laboratories ASA, an artificial intelligence (AI) software company, engages in the provision of AI virtual smart sensors for the smartphone, laptop, Internet of Things, and automotive industries in Norway, the United States, China, South Korea, Taiwan, and Japan. The company offers AI Virtual Human Presence Sensor, a presence-detection solution used to improve the security of data stored on devices and to allow intuitive responses based on natural human interaction; AI Virtual Proximity Sensor that enables exquisite full-screen devices; and AI Virtual Connection Sensor that allows to pair and authenticate smart devices in the same room. It also provides AI Virtual Position Sensor which automatically detects the location of an external display in relation to a laptop; AI Virtual Gesture Sensor, a touch-free ultrasound gesture technology, that enables touchless user interactions; AI Virtual Breathing sensor that enables to track person's breathing; and AI Virtual heart Sensor that tracks a person's heart rate. The company was incorporated in 2006 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ELLIPTIC LABORATOR jumping 4.78% to €10.96 on Wednesday while Oslo Børs Benchmark Index_GI jumped 0.04% to €1,428.23.

Earnings Per Share

As for profitability, ELLIPTIC LABORATOR has a trailing twelve months EPS of kr-0.24.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -7.11%.

More news about ELLIPTIC LABORATOR.

10. APERAM (APAM.AS)

4.26% Price Change

Aperam S.A., together with its subsidiaries, produces and sells stainless and specialty steel products worldwide. It operates through four segments: Stainless & Electrical Steel; Services & Solutions; Alloys & Specialties; and Recycling & Renewables. The company offers a range of stainless steel products, including grain oriented and non-grain oriented electrical steel products, and specialty alloys. It is also involved in the management of direct sales of stainless steel products from production facilities; distribution of its products; and the provision of transformation services that include value added and customized steel solutions. In addition, the company designs, produces, and transforms various specialty alloys and other specific stainless steels in forms, such as bars, semis, cold-rolled strips, wire and wire rods, and plates in a range on grades. Further, it engages in the trading, processing, and recycling of raw materials, such as superalloys and titanium; provides Recyco, an electric arc furnace recycling facility that retrieves dust and sludge to recycle stainless steel raw materials and reduce waste; and produces wood and charcoal from cultivated eucalyptus forests. The company serves customers in aerospace, automotive, catering, construction, household appliances, electrical engineering, industrial processes, medical, and oil and gas industries. It distributes its products through a network of steel service centers, transformation facilities, and sales offices. The company was incorporated in 2010 and is headquartered in Luxembourg, Luxembourg.

AEX-Index ended the session with APERAM jumping 4.26% to €25.94 on Wednesday, after four successive sessions in a row of gains. AEX-Index jumped 0.7% to €931.09, following the last session’s upward trend on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, APERAM has a trailing twelve months EPS of €0.7.

PE Ratio

APERAM has a trailing twelve months price to earnings ratio of 37.06. Meaning, the purchaser of the share is investing €37.06 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.57%.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Aug 16, 2024, the estimated forward annual dividend rate is 2 and the estimated forward annual dividend yield is 8.29%.

Moving Average

APERAM’s value is below its 50-day moving average of €26.08 and under its 200-day moving average of €28.20.

More news about APERAM.

Losers Today

1. MKB Nedsense (NEDSE.AS)

-10% Price Change

MKB Nedsense N.V. engages in the financing and lending of funds to natural persons and legal entities. It provides guarantees and/or other securities to third parties for its obligations and/or for obligations for companies in the investment portfolio. The company was formerly known as Nedsense Enterprises N.V. MKB Nedsense N.V. was founded in 1999 and is based in Bussum, the Netherlands.

AEX-Index ended the session with MKB Nedsense dropping 10% to €0.07 on Wednesday, following the last session’s downward trend. AEX-Index jumped 0.7% to €931.09, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.73%.

More news about MKB Nedsense.

2. CELYAD ONCOLOGY (CYAD.BR)

-9.2% Price Change

Celyad Oncology SA, a biopharmaceutical company, focuses on the research and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. The company is developing shRNA non-gene-edited technology, which allows for the development of allogenic CAR T-cells through the modulation of genes encoding the TCR without the need for gene editing; multi-specific CAR T-cell platform that focuses on the NKG2D receptor; NKG2D-based CAR T-cell therapies; and B7-H6 targeting CAT T-cell therapies. It has licensing agreement with Novartis International AG regarding the United States patents related to allogeneic CAR-T cells; and research and development collaboration, and license agreements with Horizon Discovery/PerkinElmer for the use of its shRNA reagents to reduce expression of one or more defined targets. The company was formerly known as Celyad SA and changed its name to Celyad Oncology SA in June 2020. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium.

BEL 20 ended the session with CELYAD ONCOLOGY dropping 9.2% to €0.26 on Wednesday, following the last session’s upward trend. BEL 20 rose 0.4% to €3,939.09, after two successive sessions in a row of gains, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, CELYAD ONCOLOGY has a trailing twelve months EPS of €-1.36.

Volatility

CELYAD ONCOLOGY’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.72%, a negative 0.31%, and a positive 3.12%.

CELYAD ONCOLOGY’s highest amplitude of average volatility was 4.19% (last week), 3.02% (last month), and 3.12% (last quarter).

More news about CELYAD ONCOLOGY.

3. BPOST (BPOST.BR)

-8.45% Price Change

bpost NV/SA, together with its subsidiaries, provides mail and parcel services to individuals, businesses, and public institutions in Belgium, rest of Europe, the United States, and internationally. It operates through Belgium, E-Logistics Eurasia, and E-Logistics North America segments. The company offers collection, transport, sorting, and distribution of addressed and non-addressed mail, printed documents, newspapers, periodicals, and parcels, as well as banking and financial products, e-commerce logistics, express delivery, and related services. It also provides transactional mails, advertising mails, press, domestic and international parcels, and logistic solutions; e-commerce fulfilment, including warehousing and handling of goods; e-commerce cross-border services, including custom duties services; operational back-office services, including call center, payment and financial, fraud and tax, administrative and document management services; and proximity and convenience services, such as the access to the network and over-the-counter service for different partners and sale of self-produced goods, as well as retail products and goods of partners, including bpost bank products; repair of electronics; and import services. The company was founded in 1830 and is headquartered in Brussels, Belgium.

BEL 20 ended the session with BPOST sliding 8.45% to €2.87 on Wednesday while BEL 20 rose 0.4% to €3,939.09.

Earnings Per Share

As for profitability, BPOST has a trailing twelve months EPS of €0.31.

PE Ratio

BPOST has a trailing twelve months price to earnings ratio of 9.26. Meaning, the purchaser of the share is investing €9.26 for every euro of annual earnings.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BPOST’s stock is considered to be oversold (<=20).

Volume

Today’s last reported volume for BPOST is 690169 which is 225.24% above its average volume of 212198.

Volatility

BPOST’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.21%, a negative 0.33%, and a positive 1.38%.

BPOST’s highest amplitude of average volatility was 1.60% (last week), 1.12% (last month), and 1.38% (last quarter).

More news about BPOST.

4. INTEROIL EXPL PROD (IOX.OL)

-7.46% Price Change

Interoil Exploration and Production ASA, together with its subsidiaries, operates as an upstream oil exploration and production company in Argentina and Colombia. It engages in the acquisition, exploration, development, and operation of oil and natural gas properties. The company's portfolio includes two producing concessions and two exploration concessions in Colombia; and one exploration and seven production concessions in Argentina. Interoil Exploration and Production ASA was incorporated in 2005 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with INTEROIL EXPL PROD sliding 7.46% to €6.48 on Wednesday, after three successive sessions in a row of losses. Oslo Børs Benchmark Index_GI jumped 0.04% to €1,428.23, following the last session’s downward trend on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, INTEROIL EXPL PROD has a trailing twelve months EPS of kr0.03.

PE Ratio

INTEROIL EXPL PROD has a trailing twelve months price to earnings ratio of 215.93. Meaning, the purchaser of the share is investing kr215.93 for every norwegian krone of annual earnings.

Yearly Top and Bottom Value

INTEROIL EXPL PROD’s stock is valued at kr6.48 at 22:40 EST, way under its 52-week high of kr11.00 and way higher than its 52-week low of kr1.75.

More news about INTEROIL EXPL PROD.

5. GENTIAN DIAGNOSTIC (GENT.OL)

-5.22% Price Change

Gentian Diagnostics ASA researches, develops, and produces biochemical reagents for use in medical diagnostics and research worldwide. The company offers in-vitro diagnostic reagents for clinical chemistry analyzers, such as Gentian Circulating Calprotectin Immunoassay, a turbidimetric immunoassay used for the measurement of calprotectin in plasma and serum for detection and assessment of inflammation; Gentian Cystatin C Immunoassay test kit, a glomerular filtration rate marker for the diagnosis and therapeutic control of renal function; Gentian Retinol-Binding Protein Immunoassay for detection of retinol-binding protein in human serum and plasma; and canine CRP immunoassay test kit, a particle-enhanced turbidimetric immunoassay for quantitative determination of canine C-reactive protein in dog plasma and serum. It also provides SARS-CoV-2 total antibody immunoassay, quantitative antibody test captures the full immune response detecting antibodies targeting the S1-subunit. In addition, the company develops NT-proBNP Immunoassay, an aid in the diagnosis, monitoring and assessment of severity in individuals suspected of having congestive heart failure which is in product development phase. Further, it offers faecal calprotectin immunoassay, provides results of calprotectin in stool supporting diagnosis of inflammatory bowel disease; and faecal pancreatic elastase immunoassay which allows analysis of pancreatic elastase in stool to aid in diagnosis of pancreatic exocrine insufficiency. The company was founded in 2001 and is headquartered in Moss, Norway.

Oslo Børs Benchmark Index_GI ended the session with GENTIAN DIAGNOSTIC dropping 5.22% to €54.50 on Wednesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI rose 0.04% to €1,428.23, following the last session’s downward trend on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, GENTIAN DIAGNOSTIC has a trailing twelve months EPS of kr-0.38.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.82%.

Yearly Top and Bottom Value

GENTIAN DIAGNOSTIC’s stock is valued at kr54.50 at 22:40 EST, below its 52-week high of kr55.00 and way above its 52-week low of kr34.80.

Volatility

GENTIAN DIAGNOSTIC’s last week, last month’s, and last quarter’s current intraday variation average was 7.57%, 1.83%, and 2.78%.

GENTIAN DIAGNOSTIC’s highest amplitude of average volatility was 8.44% (last week), 3.49% (last month), and 2.78% (last quarter).

More news about GENTIAN DIAGNOSTIC.

6. NYKODE THERAPEUTIC (NYKD.OL)

-5% Price Change

Nykode Therapeutics AS, a clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies. The company develops vaccines for the treatment cancer and infectious diseases. Its lead product candidates include VB10.NEO, a cancer neoantigen vaccine, which is in phase I/IIa clinical trial for the treatment of ,melanoma, lung, bladder, renal, head, and neck cancer; VB10.16, a therapeutic vaccine, which in phase II clinical trial for the treatment of human papilloma virus 16 induced malignancies, such as cervical cancer; and VB10. COV2, a COVID-19 vaccine candidate covers new SARS-CoV-2 variants. The company has collaboration agreements with Roche, Genentech, MSD, and Nektar Therapeutics; Adaptive Biotechnologies for T cell vaccine development; and research agreement with Regeneron. Nykode Therapeutics AS was founded in 2006 and is based in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with NYKODE THERAPEUTIC sliding 5% to €13.88 on Wednesday, after two successive sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.04% to €1,428.23, following the last session’s downward trend on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, NYKODE THERAPEUTIC has a trailing twelve months EPS of kr-1.39.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -25.89%.

Moving Average

NYKODE THERAPEUTIC’s worth is under its 50-day moving average of kr14.43 and way under its 200-day moving average of kr17.55.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is a negative 46.9% and a negative 51.6%, respectively.

Volume

Today’s last reported volume for NYKODE THERAPEUTIC is 935409 which is 14.71% above its average volume of 815420.

Yearly Top and Bottom Value

NYKODE THERAPEUTIC’s stock is valued at kr13.88 at 22:40 EST, way below its 52-week high of kr30.18 and way higher than its 52-week low of kr12.38.

More news about NYKODE THERAPEUTIC.

7. SKUE SPAREBANK (SKUE.OL)

-4.12% Price Change

Skue Sparebank provides various banking products and services for individual and business in Norway. The company offers operating, tax deduction, capital, client, deposit, and group accounts; business, construction, consumer, car, other vehicle, and small loans, as well as mortgage, bank guarantee, factoring, overdraft, and leasing services; and home and leisure, car and other vehicles, animal, company and employees, agriculture insurance products. It also provides savings and pension products; and online and mobile banking, bank card, and payment services. The company was formerly known as Nes Prestegjelds Sparebank and changed its name to Skue Sparebank in October 2013. Skue Sparebank was founded in 1842 and is based in Geilo, Norway.

Oslo Børs Benchmark Index_GI ended the session with SKUE SPAREBANK falling 4.12% to €230.10 on Wednesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI jumped 0.04% to €1,428.23, following the last session’s downward trend on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, SKUE SPAREBANK has a trailing twelve months EPS of kr100.27.

PE Ratio

SKUE SPAREBANK has a trailing twelve months price to earnings ratio of 2.29. Meaning, the purchaser of the share is investing kr2.29 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.19%.

More news about SKUE SPAREBANK.

8. IDEX BIOMETRICS (IDEX.OL)

-3.84% Price Change

IDEX Biometrics ASA, together with its subsidiaries, designs, develops, and sells fingerprint authentication solutions in Norway, Europe, the Middle East, Africa, the Americas, and the Asia-Pacific regions. The company's fingerprint authentication solutions are used primarily in contactless smart cards, that includes financial payment and access control cards, as well as card-based devices for the storage of digital currencies. It primarily serves smart card manufacturers and similar solution integrators. The company was incorporated in 1996 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with IDEX BIOMETRICS falling 3.84% to €1.45 on Wednesday while Oslo Børs Benchmark Index_GI jumped 0.04% to €1,428.23.

Earnings Per Share

As for profitability, IDEX BIOMETRICS has a trailing twelve months EPS of kr-1.07.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -223.25%.

More news about IDEX BIOMETRICS.

9. OCEANTEAM (OTS.OL)

-3.83% Price Change

Oceanteam ASA does not have significant operations. Previously, it engaged in a subsea and offshore business. The company was formerly known as Oceanteam Shipping ASA and changed its name to Oceanteam ASA in December 2015. Oceanteam ASA was incorporated in 2005 and is headquartered in Baerum, Norway.

Oslo Børs Benchmark Index_GI ended the session with OCEANTEAM sliding 3.83% to €1.01 on Wednesday while Oslo Børs Benchmark Index_GI rose 0.04% to €1,428.23.

Earnings Per Share

As for profitability, OCEANTEAM has a trailing twelve months EPS of kr-0.24.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.79%.

Moving Average

OCEANTEAM’s worth is under its 50-day moving average of kr1.09 and way below its 200-day moving average of kr1.30.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, OCEANTEAM’s stock is considered to be oversold (<=20).

Revenue Growth

Year-on-year quarterly revenue growth declined by 33.3%, now sitting on 60k for the twelve trailing months.

More news about OCEANTEAM.

10. SELVAAG BOLIG (SBO.OL)

-3.64% Price Change

Selvaag Bolig ASA, a housing development company, engages in the development, construction, and sale of residential properties primarily in Greater Oslo, Bergen, Stavanger, Trondheim, and Stockholm. It operates through Property Development and Other segments. The company also offers project management services. Selvaag Bolig ASA was incorporated in 2008 and is headquartered in Oslo, Norway. Selvaag Bolig ASA operates as a subsidiary of Selvaag AS.

Oslo Børs Benchmark Index_GI ended the session with SELVAAG BOLIG dropping 3.64% to €37.05 on Wednesday, after four successive sessions in a row of gains. Oslo Børs Benchmark Index_GI jumped 0.04% to €1,428.23, following the last session’s downward trend on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, SELVAAG BOLIG has a trailing twelve months EPS of kr2.52.

PE Ratio

SELVAAG BOLIG has a trailing twelve months price to earnings ratio of 14.7. Meaning, the purchaser of the share is investing kr14.7 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.85%.

More news about SELVAAG BOLIG.

Stay up to date with our winners and losers daily report